Keywords: USA, FDA, GAO, Regulation, Clinical trial investigators

US GAO calls for faster FDA action to debar disqualified investigators

Article | 23 October 2009

Print This

Following a request to the USA’s Government Accountability office to review the Food and Drug Administration’s debarment and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in